Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Maynard CL et al. – The authors highlight recent advances in the understanding of effector T cell biology in the context of intestinal immune regulation and speculate on their potential clinical significance.

   

Related Articles

IBD drugs and cancer risk
JAMA, 11/18/09    Relevance Score: 87%

Pediatric Inflammatory Bowel Disease: Highlighting Pediatric Differences in IBD
Gastroenterology Clinics of North America, 11/13/09    Relevance Score: 87%

Diagnostic Role and Clinical Association of ASCA and ANCA in Brazilian Patients with Inflammatory Bowel Disease
Digestive Diseases and Sciences, 10/19/09    Relevance Score: 87%

Safety Profile of IBD Therapeutics: Infectious Risks
Gastroenterology Clinics of North America, 11/19/09    Relevance Score: 85%

Safety Profile of IBD: Lymphoma Risks
Gastroenterology Clinics of North America, 11/16/09    Relevance Score: 85%

Today in Gastroenterology...keeping you current

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09

PRKCSH/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2/TRPP2 against HERP-mediated degradation
Human Molecular Genetics, 12/15/09

Endoscopic Nodular Gastritis in Dyspeptic Adults: Prevalence and Association with Helicobacter pylori Infection
Medical Principles and Practice, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address